286 related articles for article (PubMed ID: 18061663)
21. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
[TBL] [Abstract][Full Text] [Related]
22. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.
Broglio F; Koetsveld Pv Pv; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Gauna C; Hofland L; Deghenghi R; Arvat E; Van Der Lely AJ; Ghigo E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4829-32. PubMed ID: 12364482
[TBL] [Abstract][Full Text] [Related]
23. Ghrelin: endocrine, metabolic and cardiovascular actions.
Broglio F; Prodam F; Me E; Riganti F; Lucatello B; Granata R; Benso A; Muccioli G; Ghigo E
J Endocrinol Invest; 2005; 28(5 Suppl):23-5. PubMed ID: 16114271
[TBL] [Abstract][Full Text] [Related]
24. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland.
Deghenghi R; Papotti M; Ghigo E; Muccioli G
J Endocrinol Invest; 2001 Jan; 24(1):RC1-3. PubMed ID: 11227737
[TBL] [Abstract][Full Text] [Related]
25. Cortistatin - a new neuroendocrine hormone?
Rubinfeld H; Shimon I
Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):106-10. PubMed ID: 17342027
[TBL] [Abstract][Full Text] [Related]
26. Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.
Arvat E; Di Vito L; Lanfranco F; Broglio F; Giordano R; Benso A; Muccioli GP; Deghenghi R; Ghigo E
J Endocrinol Invest; 1999 Feb; 22(2):91-7. PubMed ID: 10195374
[TBL] [Abstract][Full Text] [Related]
27. Nocturnal ghrelin, ACTH, GH and cortisol secretion after sleep deprivation in humans.
Schüssler P; Uhr M; Ising M; Weikel JC; Schmid DA; Held K; Mathias S; Steiger A
Psychoneuroendocrinology; 2006 Sep; 31(8):915-23. PubMed ID: 16814473
[TBL] [Abstract][Full Text] [Related]
28. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor.
Ghigo E; Broglio F; Arvat E; Maccario M; Papotti M; Muccioli G
Clin Endocrinol (Oxf); 2005 Jan; 62(1):1-17. PubMed ID: 15638864
[TBL] [Abstract][Full Text] [Related]
29. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
Muccioli G; Pons N; Ghè C; Catapano F; Granata R; Ghigo E
Eur J Pharmacol; 2004 Sep; 498(1-3):27-35. PubMed ID: 15363972
[TBL] [Abstract][Full Text] [Related]
30. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
Di Vito L; Broglio F; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916
[TBL] [Abstract][Full Text] [Related]
31. Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead.
Gahete MD; Durán-Prado M; Luque RM; Martínez-Fuentes AJ; Vázquez-Martínez R; Malagón MM; Castaño JP
Mol Cell Endocrinol; 2008 May; 286(1-2):128-34. PubMed ID: 18215456
[TBL] [Abstract][Full Text] [Related]
32. The role of cortistatin in the human immune system.
van Hagen PM; Dalm VA; Staal F; Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):141-7. PubMed ID: 18450367
[TBL] [Abstract][Full Text] [Related]
33. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
[TBL] [Abstract][Full Text] [Related]
34. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers.
Frieboes RM; Antonijevic IA; Held K; Murck H; Pollmächer T; Uhr M; Steiger A
Psychoneuroendocrinology; 2004 Aug; 29(7):851-60. PubMed ID: 15177700
[TBL] [Abstract][Full Text] [Related]
35. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological profile of somatostatin and cortistatin receptors.
Siehler S; Nunn C; Hannon J; Feuerbach D; Hoyer D
Mol Cell Endocrinol; 2008 May; 286(1-2):26-34. PubMed ID: 18243519
[TBL] [Abstract][Full Text] [Related]
37. Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans.
Arvat E; Maccagno B; Ramunni J; Giordano R; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
Eur J Endocrinol; 2000 Nov; 143(5):601-6. PubMed ID: 11078983
[TBL] [Abstract][Full Text] [Related]
38. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans.
Broglio F; Benso A; Gottero C; Prodam F; Gauna C; Filtri L; Arvat E; van der Lely AJ; Deghenghi R; Ghigo E
J Endocrinol Invest; 2003 Mar; 26(3):192-6. PubMed ID: 12809167
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
Muccioli G; Baragli A; Granata R; Papotti M; Ghigo E
Neuroendocrinology; 2007; 86(3):147-64. PubMed ID: 17622734
[TBL] [Abstract][Full Text] [Related]
40. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.
Cassoni P; Allia E; Marrocco T; Ghè C; Ghigo E; Muccioli G; Papotti M
J Endocrinol Invest; 2006 Oct; 29(9):781-90. PubMed ID: 17114908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
